Antonio Alexandre de Vasconcelos Junior

Mr. Antonio Alexandre de Vasconcelos Junior

CNM, Instituto de Salud Carlos III, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
EMEverardo Albuquerque Menezes
Everardo Albuquerque Menezes
AJAntonio Alexandre de Vasconcelos Junior
Antonio Alexandre de Vasconcelos Junior
CSCarlla Lorena Façanha Silva
Carlla Lorena Façanha Silva
FPFábio Ximenes Plutarco
Fábio Ximenes Plutarco
MCMaria da Conceição dos Santos Oliveira Cunha
Maria da Conceição dos Santos Oliveira Cunha
FCFrancisco Afrânio Cunha
Francisco Afrânio Cunha
Systemic fungal infections are responsible for high mortality rates. Several species of fungi may be involved, but Candida spp. is the most prevalent. Simvastatin is used to lower cholesterol and also exhibits antifungal action. The aim of this study was to evaluate the synergistic action of simvastatin with fluconazole against strains of Candida spp. Susceptibility testing was performed according to protocol M27-A3, by broth microdilution method and the synergistic effect of simvastatin and fluconazole was calculated based on FICI (Fractional Inhibitory Concentration Index). Eleven strains were evaluated, and simvastatin showed a synergistic effect with fluconazole against 10 (91%) of the Candida spp. strains tested. Simvastatin may be a valuable drug in the treatment of systemic infections caused by Candida spp.

1 February 2012 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
EMEverardo Albuquerque Menezes
Everardo Albuquerque Menezes
JMJosé Arlécio de Sousa Marinho
José Arlécio de Sousa Marinho
MAMaria Rozzelê F. Angelo
Maria Rozzelê F. Angelo
MCMaria da Conceição dos Santos Oliveira Cunha
Maria da Conceição dos Santos Oliveira Cunha
FCFrancisco Afrânio Cunha
Francisco Afrânio Cunha
AJAntonio Alexandre de Vasconcelos Junior
Antonio Alexandre de Vasconcelos Junior
Trichosporon spp. are yeasts capable of causing invasive disease, which mainly affect immunocompromised patients. A clinical strain of T. asahii was isolated from the blood cultures of patients admitted to the General Hospital of Fortaleza. Susceptibility tests were conducted by disk diffusion and broth microdilution. The isolated strain of T. asahii was resistant to fluconazole. The patient used amphotericin B and caspofungin in order to facilitate the microbiological cure. It was the first isolation and identification of T. asahii in blood culture in Ceará, Brazil.

Verified
Journal Article
Open access
PDF file
AJAntonio Alexandre de Vasconcelos Junior
Antonio Alexandre de Vasconcelos Junior
JVJosé Manuel Tirado Vélez
José Manuel Tirado Vélez
Antonio J. Martin-GalianoAntonio J. Martin-Galiano
Antonio J. Martin-Galiano
DMDiego Megias
Diego Megias
MFMaria Jose Ferrandiz
Maria Jose Ferrandiz
ACAdela G. De La Campa
Adela G. De La Campa
The DNA topoisomerases gyrase and topoisomerase I as well as the nucleoid-associated protein HU maintain supercoiling levels in Streptococcus pneumoniae, a main human pathogen. Here, we characterized, for the first time, a topoisomerase I regulator protein (StaR). In the presence of sub-inhibitory novobiocin concentrations, which inhibit gyrase activity, higher doubling times were observed in a strain lacking staR, and in two strains in which StaR was over-expressed either under the control of the ZnSO4-inducible PZn promoter (strain ΔstaRPZnstaR) or of the maltose-inducible PMal promoter (strain ΔstaRpLS1ROMstaR). These results suggest that StaR has a direct role in novobiocin susceptibility and that the StaR level needs to be maintained within a narrow range. Treatment of ΔstaRPZnstaR with inhibitory novobiocin concentrations resulted in a change of the negative DNA supercoiling density (σ) in vivo, which was higher in the absence of StaR (σ = −0.049) than when StaR was overproduced (σ = −0.045). We have located this protein in the nucleoid by using super-resolution confocal microscopy. Through in vitro activity assays, we demonstrated that StaR stimulates TopoI relaxation activity, while it has no effect on gyrase activity. Interaction between TopoI and StaR was detected both in vitro and in vivo by co-immunoprecipitation. No alteration of the transcriptome was associated with StaR amount variation. The results suggest that StaR is a new streptococcal nucleoid-associated protein that activates topoisomerase I activity by direct protein-protein interaction.

3 March 2011 in Mycopathologia
Verified
Journal Article
Closed access
PDF file
AJAntonio Alexandre de Vasconcelos Junior
Antonio Alexandre de Vasconcelos Junior
EMEverardo Albuquerque Menezes
Everardo Albuquerque Menezes
FCFrancisco Afrânio Cunha
Francisco Afrânio Cunha

1 December 2012 in Jornal Brasileiro de Patologia e Medicina Laboratorial
Verified
Journal Article
Open access
EMEverardo Albuquerque Menezes
Everardo Albuquerque Menezes
AJAntonio Alexandre de Vasconcelos Junior
Antonio Alexandre de Vasconcelos Junior
FCFrancisco Afrânio Cunha
Francisco Afrânio Cunha
MCMaria Conceição dos Santos Oliveira Cunha
Maria Conceição dos Santos Oliveira Cunha
BBBárbara Helena Lima Braz
Bárbara Helena Lima Braz
CSCarlla Lorena Façanha Silva
Carlla Lorena Façanha Silva

1 February 2013 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
EMEverardo Albuquerque Menezes
Everardo Albuquerque Menezes
AJAntonio Alexandre de Vasconcelos Junior
Antonio Alexandre de Vasconcelos Junior
MÂMaria Rozzelê Ferreira Ângelo
Maria Rozzelê Ferreira Ângelo
MCMaria da Conceição dos Santos Oliveira Cunha
Maria da Conceição dos Santos Oliveira Cunha
FCFrancisco Afrânio Cunha
Francisco Afrânio Cunha
Key words: Disk diffusion; Antifungal susceptibility; Fluconazole